Moreover, tumour-suppressing pathways such as TP53 are commonly thought to function as a signal termination mechanism; therefore, the overall downregulation of genes is likely paramount to its function as a tumour-suppressing pathway, which further reinforces the downregulatory properties of SPAG5 when included in the pathway as a regulatory mechanism (Brandon et al. 2016). Here, TP53 is linked to neoplasm.